(Q36827319)

16 August 2017

0 references

Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapy (English)

1 reference

16 August 2017

1 reference

1 reference

Houria Hendel-Chavez

1

1 reference

16 August 2017

Marie-Ghislaine de Goër de Herve

2

1 reference

16 August 2017

Claire Giannesini

3

1 reference

16 August 2017

Anne-Aurélie Mazet

4

1 reference

16 August 2017

Caroline Papeix

5

1 reference

16 August 2017

Céline Louapre

6

1 reference

16 August 2017

Audrey Chardain

7

1 reference

16 August 2017

Nassima Boutarfa

8

1 reference

16 August 2017

Marie Théaudin

9

1 reference

16 August 2017

David Adams

10

1 reference

16 August 2017

Jacques Gasnault

11

1 reference

16 August 2017

Bruno Stankoff

12

1 reference

16 August 2017

Yassine Taoufik

13

1 reference

16 August 2017

language of work or name

English

0 references

publication date

20 March 2013

1 reference

16 August 2017

1 reference

16 August 2017

87

1 reference

16 August 2017

10

1 reference

16 August 2017

6055-6059

1 reference

Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Progressive multifocal leukoencephalopathy and other forms of JC virus disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Asymptomatic reactivation of JC virus in patients treated with natalizumab

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

New trends in progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Maintenance of serum antibody levels

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Cutting edge: cross-presented intracranial antigen primes CD8+ T cells.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

High incidence of urinary JC virus excretion in nonimmunosuppressed older patients

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Anti-JC virus antibodies: implications for PML risk stratification

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Duration of humoral immunity to common viral and vaccine antigens

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Presence, quantitation and characterization of JC virus in the urine of Italian immunocompetent subjects

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Initiation of immune responses in brain is promoted by local dendritic cells.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648156

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

5 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23514886

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immunosuppression increases latent infection of brain by JC polyomavirus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23514886

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/JVI.00131-13

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

23514886

1 reference